{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T03:35:25Z","timestamp":1776137725467,"version":"3.50.1"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Fibrinogen A alpha-chain amyloidosis (AFib amyloidosis) is the most common form of hereditary renal amyloidosis in the United Kingdom and Europe, but has rarely been reported in Asia. In this study, we reported two AFib amyloidosis patients in China, reviewing the literature and summarizing main characteristics of AFib amyloidosis in Asia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Two unrelated Chinese patients were diagnosed with AFib amyloidosis by clinical presentation, renal biopsy, mass spectrometry and DNA sequencing in Peking University First Hospital of China from 2014 to 2016.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Both of the patients presented with proteinuria, edema and hypertension. Renal biopsies of two patients showed extensive amyloid deposits (Congo red positive) in glomeruli, and focal tubulointerstitial amyloid deposits was also found in patient 1. Besides, hepatic involvement of amyloidosis has been detected by liver biopsy in patient 1. By electron microscopy, randomly arranged fibrils in a diameter of 8\u201312 nm was identified in mesangial matrix and subendothelial area of glomeruli. Immunohistochemistry demonstrated amyloid deposits were strongly positive for fibrinogen A\u03b1 in glomeruli and positive for LECT2 in the interstitium of renal medulla and the liver in Patient 1. Unevenly positive staining for both fibrinogen A\u03b1 and ApoA-I were found in Patient 2. Fibrinogen A\u03b1 was the most abundant amyloidogenic protein in both patients identified by laser microdissection and mass spectrometry-based proteomic analysis. Genetic analysis revealed the <jats:italic>fibrinogen A a-chain<\/jats:italic> gene (<jats:italic>FGA<\/jats:italic>) mutation in both patients, including a new deletion mutation [c.1639delA (p.Arg547Glyfs<jats:sup>*<\/jats:sup>21; NM_000508)] in Patient 2. Genetic analysis of the <jats:italic>LECT2<\/jats:italic> gene in patient 1 revealed a codon change from ATC to GTC at position 172 [c.172A&amp;gt;G (p.Ile58Val; NM_002302)], which is a common polymorphism (SNP rs31517) in all ALECT2 amyloidosis patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We reported two AFib amyloidosis patients in China, one of them coexisted with ALECT2 amyloidosis simultaneously.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.869409","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T14:42:40Z","timestamp":1651156960000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Fibrinogen A Alpha-Chain Amyloidosis in Two Chinese Patients"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhen-Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Juan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-De","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ng0393-252","article-title":"Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain","volume":"3","author":"Benson","year":"1993","journal-title":"Nat Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1182\/blood-2009-06-223792","article-title":"Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation","volume":"115","author":"Stangou","year":"2010","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms19010320","article-title":"Hereditary fibrinogen aalpha-chain amyloidosis in asia: clinical and molecular characteristics","author":"Yazaki","year":"2018","journal-title":"Int J Molec Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2215\/CJN.07030712","article-title":"Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy","volume":"8","author":"Sethi","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0021-9150(91)90053-6","article-title":"Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia","volume":"89","author":"Talmud","year":"1991","journal-title":"Atherosclerosis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/13506129.2012.763029","article-title":"Fibrinogen A alpha-chain amyloidosis: report of the first case in Latin America","volume":"20","author":"Machado","year":"2013","journal-title":"Amyloid: Int J Exper Clin Invest."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1182\/blood-2012-09-306639","article-title":"Mechanisms of fibrin polymerization and clinical implications","volume":"121","author":"Weisel","year":"2013","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms18122711","article-title":"Fibrinogen as a pleiotropic protein causing human diseases: the mutational burden of Aalpha, Bbeta, and gamma chains","author":"Paraboschi","year":"2017","journal-title":"Int J Molec Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ekir.2019.04.007","article-title":"Proteomic analysis for the diagnosis of fibrinogen aalpha-chain amyloidosis","volume":"4","author":"Taylor","year":"2019","journal-title":"Kidney Int Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1111\/j.1523-1755.2005.00653.x","article-title":"Hereditary amyloidosis in early childhood associated with a novel insertion-deletion (indel) in the fibrinogen Aalpha chain gene","volume":"68","author":"Kang","year":"2005","journal-title":"Kidney Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1681\/ASN.2008060614","article-title":"Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis","volume":"20","author":"Gillmore","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3969\/j.issn.1671-167X.2014.05.026","article-title":"Hereditary fibrinogen Aalpha-chain amyloidosis caused by the E526V mutation: a case report and literature review","volume":"46","author":"Yao","year":"2014","journal-title":"J Peking Univ Health Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/13506129.2015.1037389","article-title":"The first pure form of Ostertag-type amyloidosis in Japan: a sporadic case of hereditary fibrinogen Aalpha-chain amyloidosis associated with a novel frameshift variant","volume":"22","author":"Yazaki","year":"2015","journal-title":"Amyloid: Int J Exper Clin Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.ekir.2021.07.014","article-title":"Fibrinogen A alpha-chain amyloidosis associated with a novel variant in a Chinese family","volume":"6","author":"Jin","year":"2021","journal-title":"Kidney Int Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1053\/j.ajkd.2017.01.048","article-title":"Unrecognized fibrinogen a alpha-chain amyloidosis: results from targeted genetic testing","volume":"70","author":"Tavares","year":"2017","journal-title":"Am J Kidney Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"100446","DOI":"10.1016\/j.jbc.2021.100446","article-title":"Loss of bound zinc facilitates amyloid fibril formation of leukocyte cell-derived chemotaxin 2 (LECT2)","volume":"296","author":"Ha","year":"2021","journal-title":"J Biol Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ekir.2016.11.005","article-title":"Renal amyloidosis associated with 5 novel variants in the fibrinogen a alpha chain protein","volume":"2","author":"Rowczenio","year":"2017","journal-title":"Kidney Int Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/13506129.2013.781998","article-title":"Hereditary amyloidosis caused by R554L fibrinogen Aalpha-chain mutation in a Spanish family and review of the literature","volume":"20","author":"Haidinger","year":"2013","journal-title":"Amyloid: Int J Exper Clin Invest."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.869409\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T14:42:45Z","timestamp":1651156965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.869409\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":18,"alternative-id":["10.3389\/fmed.2022.869409"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.869409","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"article-number":"869409"}}